The Launceston General Hospital is one of the three main public hospitals in Tasmania, Australia. It is located in Launceston and serves the north of the state.

There are 308 (+ 41 day care) beds in Launceston General Hospital; Gastroenterology Research.

During the past decade, Launceston General Hospital; Gastroenterology Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Launceston General Hospital; Gastroenterology Research" are "Ulcerative Colitis" (2 trials), "Malignant Melanoma" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Launceston General Hospital; Gastroenterology Research" in a lesser frequency.

Most popular intervention types in "Launceston General Hospital; Gastroenterology Research" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Vemurafenib" (2 trials), "Cobimetinib" (1 trials), "Etrolizumab" (1 trials) and "Etrozulimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Launceston General Hospital; Gastroenterology Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Launceston General Hospital; Gastroenterology Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Launceston General Hospital; Gastroenterology Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Launceston General Hospital; Gastroenterology Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".